Open-Label Extension of Studies ATH-1017-0201 and ATH-1017-0202 in Subjects with Mild to Moderate Alzheimer¿s Disease
Clinical Trial Grant
Administered By
Neurology, Behavioral Neurology
Awarded By
Athira Pharma, Inc.
Start Date
October 6, 2021
End Date
December 31, 2024
Administered By
Neurology, Behavioral Neurology
Awarded By
Athira Pharma, Inc.
Start Date
October 6, 2021
End Date
December 31, 2024